Cryopreservation and Thawing of Ex Vivo Expanded Cord Blood Hematopoietic Stem Cells [0.03%]
体外扩增的脐血造血干细胞的冻存及复苏
Lia Morton,Induja Arulchelvam,Chelsea McGregor et al.
Lia Morton et al.
Background: Umbilical cord blood (CB) is an invaluable source of hematopoietic stem and progenitor cells (HSPCs). Its use in stem cell transplantation is however constrained by the insufficient cell dose present in each u...
Interactive Effect of Age on Overall and Relative Survival Benefits of Radiotherapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era [0.03%]
利妥昔单抗时代年龄对早期弥漫大B细胞淋巴瘤放射治疗总生存和相对生存的影响分析
Xin Wang,Xin Liu,Qiu Zi Zhong et al.
Xin Wang et al.
Background: The aim of the study was to determine the interactive effect of age on overall survival (OS) and relative survival (RS) benefits of radiotherapy (RT) in early-stage diffuse large B-cell lymphoma (DLBCL). ...
Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients - Real World Data from Hungary [0.03%]
达雷妥尤单抗、来那度胺和地塞米松治疗多发性骨髓瘤患者首次复发的疗效和安全性：来自匈牙利的真实世界数据
Szilvia Lovas,Nora Obajed Al-Ali,Katalin Farkas et al.
Szilvia Lovas et al.
Background: Daratumumab is a monoclonal antibody targeting CD38, which has demonstrated efficacy in both newly diagnosed and relapsed or refractory multiple myeloma (MM). The objective of our study was to evaluate the eff...
Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma [0.03%]
奥利扎布替尼治疗复发/难治边缘区淋巴瘤的有效性和安全性
Shi Lv Chen,Yu Feng,Jiao Xue et al.
Shi Lv Chen et al.
Background: This study aimed to investigate the efficacy and safety of orelabrutinib monotherapy in Chinese patients with marginal zone B-cell lymphoma (MZL). ...
A Complex Case of Hemophagocytic Lymphohistiocytosis Secondary to Untreated Hepatitis C: Diagnostic Challenges [0.03%]
由未经治疗的丙型肝炎继发的噬血细胞淋巴组织细胞增生症复杂病例的诊断挑战
Zachrieh Alhaj,Alexander Konopnicki,Zaid Almubaid et al.
Zachrieh Alhaj et al.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome caused by uncontrolled activation of cytotoxic T cells and macrophages, leading to cytokine storm and organ failure. Secondary HLH is the acquired for...
Case Reports
Journal of hematology. 2025 Dec 30;14(6):324-328. DOI:10.14740/jh2101 2025
Outcomes of Hematopoietic Stem Cell Transplantation Following the Use of Blinatumomab in Pediatric Relapsed B-Cell Acute Lymphoblastic Leukemia: A Single-Center Experience [0.03%]
关于反式细胞在儿童复发B细胞急性淋巴细胞白血病中的应用后进行造血干细胞移植的效果：一项单中心经验研究
Aditi Tulsiyan,Anuj Singh,Nita Radhakrishnan et al.
Aditi Tulsiyan et al.
Background: Relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) remains associated with poor outcomes in children. Achieving measurable residual disease (MRD) negativity prior to allogeneic hematopoietic...
Ibrahim Elsharawi,Christopher Liwski
Ibrahim Elsharawi
The gastrointestinal tract is the most frequent extranodal site for lymphomas. Primary gastrointestinal B-cell lymphomas represent a distinct group of lymphoproliferative disorders and are the most common type of gastrointestinal lymphomas....
Bilateral Avascular Necrosis of the Hips in a Patient With Sickle Cell Trait and Chronic Alcohol Use [0.03%]
sickle细胞病 trait和慢性饮酒引起的双侧股骨头无血管坏死
Sarah Al-Zaher,Janan Niknam,Sivarama K Kotikalapudi
Sarah Al-Zaher
Sickle cell trait (SCT) is generally considered a benign carrier state, unlike sickle cell disease (SCD), which is frequently associated with complications such as avascular necrosis (AVN). While AVN affects approximately 30% of patients wi...
Case Reports
Journal of hematology. 2025 Oct 10;14(5):262-266. DOI:10.14740/jh2084 2025
Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program [0.03%]
重度甲型血友病患者使用emicizumab的临床和患者转归指标：在标准化项目中的评估结果分析
Ingrid Blydt-Hansen,Michelle Bech,Shannon Jackson
Ingrid Blydt-Hansen
Background: Emicizumab (Hemlibra) became more accessible for Canadians in 2021, when Canadian Blood Services approved it under formulary for prophylaxis in patients with severe hemophilia A (PWHA) without inhibitors. This...
Hala Alsoukhni,Dima Al-Dabbas,Mohammad Masalha et al.
Hala Alsoukhni et al.
Acute undifferentiated leukemia (AUL) is a rare, aggressive type of acute leukemia associated with poor prognosis, in which the blasts lack lineage commitment to either the myeloid or lymphoid lineages. It is classified according to the Wor...
Case Reports
Journal of hematology. 2025 Oct 10;14(5):267-272. DOI:10.14740/jh2090 2025